These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1615498)

  • 1. The bleeding time in normal subjects is mainly determined by platelet von Willebrand factor and is independent from blood group.
    Rodeghiero F; Castaman G; Ruggeri M; Tosetto A
    Thromb Res; 1992 Mar; 65(4-5):605-15. PubMed ID: 1615498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor.
    Mannucci PM; Lombardi R; Bader R; Vianello L; Federici AB; Solinas S; Mazzucconi MG; Mariani G
    Blood; 1985 Oct; 66(4):796-802. PubMed ID: 3876122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimeric pattern of plasma and platelet von Willebrand factor is normal in uremic patients.
    Castaman G; Rodeghiero F; Lattuada A; La Greca G; Mannucci PM
    Am J Hematol; 1993 Dec; 44(4):266-9. PubMed ID: 8237998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis.
    Drouin J; Lillicrap DP; Izaguirre CA; Sutherland M; Windsor S; Benford K; Hoogendorn H; Giles AR
    Am J Clin Pathol; 1989 Oct; 92(4):471-8. PubMed ID: 2508465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis. Cooperative Study Groups.
    Menache D; Aronson DL; Darr F; Montgomery RR; Gill JC; Kessler CM; Lusher JM; Phatak PD; Shapiro AD; Thompson AR; White GC
    Br J Haematol; 1996 Sep; 94(4):740-5. PubMed ID: 8826903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excessive prolongation of the bleeding time by aspirin in essential thrombocythemia is related to a decrease of large von Willebrand factor multimers in plasma.
    van Genderen PJ; van Vliet HH; Prins FJ; van de Moesdijk D; van Strik R; Zijlstra FJ; Budde U; Michiels JJ
    Ann Hematol; 1997; 75(5-6):215-20. PubMed ID: 9433378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
    Michiels JJ; van Vliet HH
    Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo experiments indicate that relatively high platelet deposition in von Willebrand's disease 'Vicenza' is caused by normal platelet-VWF levels rather than by high VWF-multimers in plasma.
    d'Alessio PA; Castaman G; Rodeghiero F; de Boer HC; Federici AB; Mannucci PM; de Groot PG; Sixma JJ; Zwaginga JJ
    Thromb Res; 1992 Jan; 65(2):221-8. PubMed ID: 1579897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet von Willebrand factor in Hermansky-Pudlak syndrome.
    McKeown LP; Hansmann KE; Wilson O; Gahl W; Gralnick HR; Rosenfeld KE; Rosenfeld SJ; Horne MK; Rick ME
    Am J Hematol; 1998 Oct; 59(2):115-20. PubMed ID: 9766795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor VIII:C increases after desmopressin in a subgroup of patients with autosomal recessive severe von Willebrand disease.
    Castaman G; Lattuada A; Mannucci PM; Rodeghiero F
    Br J Haematol; 1995 Jan; 89(1):147-51. PubMed ID: 7833254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of the largest platelet-von Willebrand multimers in a patient with lactoferrin deficiency and a bleeding tendency.
    Parker RI; McKeown LP; Gallin JI; Gralnick HR
    Thromb Haemost; 1992 Mar; 67(3):320-4. PubMed ID: 1641822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
    Aihara M; Kimura A; Chiba Y; Yoshida Y
    Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet von Willebrand factor.
    Gralnick HR; Williams SB; McKeown LP; Magruder L; Hansmann K; Vail M; Parker RI
    Mayo Clin Proc; 1991 Jun; 66(6):634-40. PubMed ID: 2046403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL; Kupinski JM; Castella A; Ruggeri ZM
    J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and platelet von Willebrand factor defects in uremia.
    Gralnick HR; McKeown LP; Williams SB; Shafer BC; Pierce L
    Am J Med; 1988 Dec; 85(6):806-10. PubMed ID: 3264111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
    Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
    Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desialylation of platelets induced by Von Willebrand Factor is a novel mechanism of platelet clearance in dengue.
    Riswari SF; Tunjungputri RN; Kullaya V; Garishah FM; Utari GSR; Farhanah N; Overheul GJ; Alisjahbana B; Gasem MH; Urbanus RT; de Groot PG; Lefeber DJ; van Rij RP; van der Ven A; de Mast Q
    PLoS Pathog; 2019 Mar; 15(3):e1007500. PubMed ID: 30849118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory Testing for von Willebrand Factor Ristocetin Cofactor (VWF:RCo).
    Mohammed S; Favaloro EJ
    Methods Mol Biol; 2017; 1646():435-451. PubMed ID: 28804846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of von Willebrand factor in essential thrombocythemia patients treated with alpha-2b recombinant interferon.
    Mazzucconi MG; Ferrari A; Solinas S; Vitale A; Chistolini A; Federici AB; Mandelli F
    Haemostasis; 1991; 21(3):135-40. PubMed ID: 1773983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.